Home / Companies / Hikma Pharmaceuticals Plc / 25 Apr 2024
Hikma Pharmaceuticals Plc: meeting of 25 Apr 2024
Votes reported on Form N-PX, item by item
134 Form N-PX filers reported votes at the Hikma Pharmaceuticals Plc meeting of 25 Apr 2024. Their records fall into 8 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
11 nominees; 96.7% of reported votes for; 30 filers withheld from or voted against at least one nominee.
2,552 vote records from 119 filers. 2 of the 118 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
41 vote records from 28 filers. 2 of the 27 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
464 vote records from 119 filers. 1 of the 118 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
SHAREHOLDER RIGHTS AND DEFENSESIssuer
SHAREHOLDER RIGHTS AND DEFENSES: management items
Management items in this category are shown together; filers word and number them differently.
920 vote records from 117 filers. 0 of the 116 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
1,157 vote records from 118 filers. 1 of the 117 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
214 vote records from 107 filers. 14 of the 106 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
444 vote records from 118 filers. 1 of the 117 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
29 vote records from 13 filers. 0 of the 13 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | No report | For |
| BlackRock and iShares | For | No report | For |
| Fidelity | For | No report | For |
| Dimensional | For | No report | For |
| State Street and SPDR | For | No report | For |
| American Century | For | No report | For |
| Franklin Templeton | For | No report | For |
| Invesco | For | No report | For |
| Equitable | For | No report | For |
| Charles Schwab | For | No report | For |
| Nuveen and TIAA | For | No report | For |
| John Hancock and Manulife | For | For | For |
| Morgan Stanley, Eaton Vance and Calvert | For | No report | For |
| J.P. Morgan | For | For | For |
| Goldman Sachs | For | No report | For |
| WisdomTree | For | No report | For |
| PGIM and Prudential | For | No report | For |
| Jackson National funds | For | For | For |
| Northern Trust and FlexShares | For | Against * | For |
| SEI | For | No report | For |
| T. Rowe Price | For | No report | For |
| Thrivent | For | No report | For |
| Lincoln Financial | For | No report | For |
| Voya | For | No report | For |
| Russell Investments | For | No report | For |
| Nationwide | For | No report | For |
| Victory Capital | For | No report | For |
| Brighthouse Funds | For | No report | For |
| BNY Mellon | For | No report | For |
| Principal | For | No report | For |
| Transamerica | For | No report | For |
| AllianceBernstein | For | No report | For |
| PIMCO | For | No report | For |
| Harbor Funds | For | For | For |
| Neuberger Berman | For * | No report | For * |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Hikma Pharmaceuticals Plc meeting?
134 Form N-PX filers reported votes at the meeting of 25 Apr 2024. On say-on-pay, 2 of 27 voted against management (7.4%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Hikma Pharmaceuticals Plc on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Hikma Pharmaceuticals Plc
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Hikma Pharmaceuticals Plc with a meeting date within three days of 25 Apr 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.